These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 11370823)

  • 21. Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas.
    Miyata H; Yamasaki M; Kurokawa Y; Takiguchi S; Nakajima K; Fujiwara Y; Konishi K; Mori M; Doki Y
    Ann Surg Oncol; 2011 Nov; 18(12):3353-61. PubMed ID: 21537861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma?
    Chen G; Wang Z; Liu XY; Liu FY
    Ann Thorac Surg; 2009 Jun; 87(6):1697-702. PubMed ID: 19463580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical treatment for carcinoma of the esophagus in the elderly patient.
    Xijiang Z; Xizeng Z; Xishan H; Hongjing J
    Ann Thorac Cardiovasc Surg; 1999 Jun; 5(3):182-6. PubMed ID: 10413765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection.
    Peyre CG; Hagen JA; DeMeester SR; Altorki NK; Ancona E; Griffin SM; Hölscher A; Lerut T; Law S; Rice TW; Ruol A; van Lanschot JJ; Wong J; DeMeester TR
    Ann Surg; 2008 Oct; 248(4):549-56. PubMed ID: 18936567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salvage surgery after failed chemoradiotherapy in squamous cell carcinoma of the esophagus.
    Chao YK; Chan SC; Chang HK; Liu YH; Wu YC; Hsieh MJ; Tseng CK; Liu HP
    Eur J Surg Oncol; 2009 Mar; 35(3):289-94. PubMed ID: 18396384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors that influence early death due to cancer recurrence after extended radical esophagectomy with three-field lymph node dissection.
    Kosugi S; Kanda T; Yajima K; Ishikawa T; Hatakeyama K
    Ann Surg Oncol; 2011 Oct; 18(10):2961-7. PubMed ID: 21499809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Survival of patients with esophageal cancer subjected to total thoracic esophagectomy].
    Braghetto I; Csendes A; Cornejo A; Amat J; Cardemil G; Burdiles P; Korn O
    Rev Med Chil; 2000 Jan; 128(1):64-74. PubMed ID: 10883524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimum treatment strategy for superficial esophageal cancer: endoscopic mucosal resection versus radical esophagectomy.
    Fujita H; Sueyoshi S; Yamana H; Shinozaki K; Toh U; Tanaka Y; Mine T; Kubota M; Shirouzu K; Toyonaga A; Harada H; Ban S; Watanabe M; Toda Y; Tabuchi E; Hayabuchi N; Inutsuka H
    World J Surg; 2001 Apr; 25(4):424-31. PubMed ID: 11344392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. En-bloc esophagectomy for esophageal cancer.
    Tachibana M; Kinugasa S; Yoshimura H; Shibakita M; Tonomoto Y; Dhar DK; Tabara H; Nagasue N
    Am J Surg; 2004 Sep; 188(3):254-60. PubMed ID: 15450830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transhiatal versus transthoracic esophagectomy: complication and survival rates.
    Boyle MJ; Franceschi D; Livingstone AS
    Am Surg; 1999 Dec; 65(12):1137-41; discussion 1141-2. PubMed ID: 10597061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term results of salvage endoscopic mucosal resection in patients with local failure after definitive chemoradiotherapy for esophageal squamous cell carcinoma.
    Yano T; Muto M; Hattori S; Minashi K; Onozawa M; Nihei K; Ishikura S; Ohtsu A; Yoshida S
    Endoscopy; 2008 Sep; 40(9):717-21. PubMed ID: 18773340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary carcinoma of the hypopharynx and cervical esophagus: evolution of surgical therapy.
    Laterza E; Mosciaro O; Urso US; Inaspettato G; Cordiano C
    Hepatogastroenterology; 1994 Jun; 41(3):278-82. PubMed ID: 7959554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [5-year survival after subtotal extensive esophagectomy for cancer].
    Collard JM; Kestens PJ
    Chirurgie; 1993-1994; 119(9):558-63; discussion 563-4. PubMed ID: 7729205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrence pattern of esophageal cancer after esophagectomy with two-field lymphadenectomy.
    Sánchez-Pernaute A; Pérez Aguirre E; Hernando Trancho F; Díez Valladares L; Ochagavía Cámara S; Calatayud Gastardi J; Torres García A; Balibrea Cantero JL
    Rev Esp Enferm Dig; 2003 Mar; 95(3):197-201, 191-6. PubMed ID: 12760709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Causes of death and pattern of recurrence after esophagectomy and extended lymphadenectomy for squamous cell carcinoma of the thoracic esophagus.
    Osugi H; Takemura M; Higashino M; Takada N; Lee S; Ueno M; Tanaka Y; Fukuhara K; Hashimoto Y; Fujiwara Y; Kinoshita H
    Oncol Rep; 2003; 10(1):81-7. PubMed ID: 12469149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Differentiated surgical therapy of esophageal carcinoma].
    Junginger T; Dutkowski P; Böttger T; Wahl W
    Chirurg; 1995 Jul; 66(7):693-703. PubMed ID: 7545571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anastomotic recurrence of oesophageal squamous cell carcinoma after transthoracic oesophagectomy.
    Kato H; Tachimori Y; Watanabe H; Yamaguchi H; Ishikawa T; Nakanishi Y; Ochiai A
    Eur J Surg; 1998 Oct; 164(10):759-64. PubMed ID: 9840305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Esophagectomy for esophageal cancer excluding cardial involvement. Analysis of 40 cases].
    Hernández Lizoáin JL; Zornoza G; Chamorro A; Ahenke A; Albiach M; Voltas J
    Rev Med Univ Navarra; 1989; 33(3):155-60. PubMed ID: 2489263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of circumferential resection margin distance on locoregional recurrence and survival after chemoradiotherapy in esophageal squamous cell carcinoma.
    Chao YK; Yeh CJ; Chang HK; Tseng CK; Chu YY; Hsieh MJ; Wu YC; Liu HP
    Ann Surg Oncol; 2011 Feb; 18(2):529-34. PubMed ID: 20697822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
    Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
    Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.